These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7504717)

  • 61. [Clinical features and treatment of hepatic tumor-like lesions].
    Guo RP; Zhong C; Shi M; Wei W; Zhang YQ; Li JQ; Li GH
    Ai Zheng; 2006 Mar; 25(3):352-4. PubMed ID: 16536993
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Contrast medium-supported sonography of the liver--a challenge to German radiology].
    Albrecht T
    Rofo; 2003 Jul; 175(7):889-91. PubMed ID: 12847642
    [No Abstract]   [Full Text] [Related]  

  • 63. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.
    Han AR; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2009; 56(93):1111-6. PubMed ID: 19760952
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
    Montagnana M; Danese E; Lippi G
    Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum C-reactive protein as a serum marker for the diagnosis of hepatocellular carcinoma.
    Lee FY; Lee SD; Tsai YT; Wu JC; Lai KH; Lo KJ
    Cancer; 1989 Apr; 63(8):1567-71. PubMed ID: 2466549
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
    Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W
    Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095
    [No Abstract]   [Full Text] [Related]  

  • 67. Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.
    Ette AI; Ndububa DA; Adekanle O; Ekrikpo U
    Niger J Clin Pract; 2017 Oct; 20(10):1267-1272. PubMed ID: 29192630
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
    Tatsuta M; Yamamura H; Iishi H; Kasugai H; Okuda S
    Oncology; 1986; 43(5):306-10. PubMed ID: 2429242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical Value of Contrast-Enhanced Ultrasound in Diagnosis of Hyperechoic Liver Lesions.
    Liu J; Wang D; Li H; Li H; Zhou T; Zhao S; Ding Z
    Med Sci Monit; 2015 Sep; 21():2845-50. PubMed ID: 26394170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Static and dynamic scintigraphy of the liver using labeled erythrocytes in the diagnosis of hepatic hemangioma].
    Hartleb M; Kloc T; Sliwiński Z
    Pol Tyg Lek; 1992 Jul 20-27; 47(29-30):646-50. PubMed ID: 1336856
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma.
    Moriyama A; Tabaru A; Unoki H; Abe S; Masumoto A; Otsuki M
    Clin Chim Acta; 2000 Jun; 296(1-2):181-91. PubMed ID: 10807981
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of the role of interleukin-6 in diagnosis of hepatocellular carcinoma.
    El-Folly RF; El-Kabarity RH; Arafa NA
    Egypt J Immunol; 2010; 17(2):11-22. PubMed ID: 23082483
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.
    Bolondi L; Benzi G; Santi V; Gaiani S; Li Bassi SL; Zironi G; Mazziotti A; Sama C; Grigioni W; Gozzetti G
    Ital J Gastroenterol; 1990 Aug; 22(4):190-4. PubMed ID: 1720058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.
    Cillo U; Giuliani T; Polacco M; Herrero Manley LM; Crivellari G; Vitale A
    World J Gastroenterol; 2016 Jan; 22(1):232-52. PubMed ID: 26755873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray.
    Wu M; Liu H; Liu Z; Liu C; Zhang A; Li N
    J Int Med Res; 2018 Oct; 46(10):4297-4305. PubMed ID: 30111217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum alpha-fetoprotein values in dogs with various hepatic diseases.
    Yamada T; Fujita M; Kitao S; Ashida Y; Nishizono K; Tsuchiya R; Shida T; Kobayashi K
    J Vet Med Sci; 1999 Jun; 61(6):657-9. PubMed ID: 10423688
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
    Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
    Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.
    Kasahara A; Hayashi N; Fusamoto H; Kawada Y; Imai Y; Yamamoto H; Hayashi E; Ogihara T; Kamada T
    Dig Dis Sci; 1993 Dec; 38(12):2170-6. PubMed ID: 7505217
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
    Yi X; Yu S; Bao Y
    Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.